canrenoic acid has been researched along with Innate Inflammatory Response in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, X; Liu, J; Liu, Z; Peng, J; Qin, K; Xie, X; Xu, L | 1 |
| Bendtzen, K; Hansen, PR; Rieneck, K | 1 |
2 other study(ies) available for canrenoic acid and Innate Inflammatory Response
| Article | Year |
|---|---|
Dexamethasone and potassium canrenoate alleviate hyperalgesia by competitively regulating IL-6/JAK2/STAT3 signaling pathway during inflammatory pain in vivo and in vitro.
Topics: Animals; Canrenoic Acid; Dexamethasone; Freund's Adjuvant; Hyperalgesia; Inflammation; Interleukin-6; Janus Kinase 2; Male; Molecular Docking Simulation; Pain; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid; Signal Transduction | 2022 |
Spironolactone inhibits production of proinflammatory cytokines by human mononuclear cells.
Topics: Aldosterone; Canrenoic Acid; Cells, Cultured; Cyproterone Acetate; Cytokines; Enzyme-Linked Immunosorbent Assay; Humans; Inflammation; Inflammation Mediators; Leukocytes, Mononuclear; Lipopolysaccharides; Phytohemagglutinins; Pregnadienes; RNA, Messenger; Spironolactone; Transcription, Genetic | 2004 |